Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)
Public ClinicalTrials.gov record NCT06829537. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension in the United States of America (MOMENTUM)
Study identification
- NCT ID
- NCT06829537
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Corcept Therapeutics
- Industry
- Enrollment
- 1,143 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 27, 2025
- Primary completion
- Dec 7, 2025
- Completion
- Jan 22, 2026
- Last update posted
- Feb 16, 2026
2025 – 2026
United States locations
- U.S. sites
- 50
- U.S. states
- 15
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 378 | Huntington Park | California | 90255 | — |
| Site 406 | La Jolla | California | 92037 | — |
| Site 538 | La Jolla | California | 92037 | — |
| Site 041 | Los Angeles | California | 90048 | — |
| Site 535 | Northridge | California | 91324 | — |
| Site 379 | Redondo Beach | California | 90247 | — |
| Site 542 | Santa Maria | California | 93454 | — |
| Site 387 | Tarzana | California | 91356 | — |
| Site 375 | Torrance | California | 90502 | — |
| Site 533 | Torrance | California | 90505 | — |
| Site 553 | Cooper City | Florida | 33024 | — |
| Site 444 | Edgewater | Florida | 32132 | — |
| Site 528 | Maitland | Florida | 32751 | — |
| Site 554 | Miami | Florida | 33126 | — |
| Site 525 | Miami | Florida | 33155 | — |
| Site 527 | Miami | Florida | 33173 | — |
| Site 537 | Port Charlotte | Florida | 33952 | — |
| Site 009 | Atlanta | Georgia | 30303 | — |
| Site 552 | Chicago | Illinois | 60607 | — |
| Site 532 | Winfield | Illinois | 60190 | — |
| Site 046 | Covington | Kentucky | 41011 | — |
| Site 061 | Metairie | Louisiana | 70006 | — |
| Site 377 | New Orleans | Louisiana | 70112 | — |
| Site 410 | Baltimore | Maryland | 21239 | — |
| Site 394 | Olney | Maryland | 20832 | — |
| Site 440 | Rockville | Maryland | 20854 | — |
| Site 067 | Boston | Massachusetts | 02115 | — |
| Site 530 | Troy | Michigan | 48085 | — |
| Site 371 | Las Vegas | Nevada | 89148 | — |
| Site 541 | Reno | Nevada | 89502 | — |
| Site 070 | Albany | New York | 12203 | — |
| Site 524 | New York | New York | 10029 | — |
| Site 181 | Chapel Hill | North Carolina | 27514 | — |
| Site 536 | Durham | North Carolina | 27701 | — |
| Site 555 | Greenville | North Carolina | 27834 | — |
| Site 529 | Mooresville | North Carolina | 28117 | — |
| Site 540 | Morrisville | North Carolina | 27560 | — |
| Site 059 | Wilmington | North Carolina | 28401 | — |
| Site 436 | Cincinnati | Ohio | 45219 | — |
| Site 551 | Cleveland | Ohio | 44109 | — |
| Site 042 | Cleveland | Ohio | 44195 | — |
| Site 195 | Columbus | Ohio | 43201 | — |
| Site 168 | Charleston | South Carolina | 29425 | — |
| Site 534 | Mt. Pleasant | South Carolina | 29464 | — |
| Site 456 | Austin | Texas | 78759 | — |
| Site 370 | Dallas | Texas | 75230 | — |
| Site 526 | Houston | Texas | 77054 | — |
| Site 408 | Lufkin | Texas | 75904 | — |
| Site 369 | San Antonio | Texas | 78229 | — |
| Site 531 | Weslaco | Texas | 78596 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06829537, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06829537 live on ClinicalTrials.gov.